Endocrine, cardiac and neuropsychological aspects of adult congenital adrenal hyperplasia
- PMID: 38572909
- DOI: 10.1111/cen.15055
Endocrine, cardiac and neuropsychological aspects of adult congenital adrenal hyperplasia
Abstract
Objective: To investigate the metabolic, cardiovascular, and neuropsychological phenotype, quality of life (QoL), and hormonal regulation in individuals with congenital adrenal hyperplasia (CAH), a group of autosomal recessive disorders characterized by impaired synthesis of cortisol in the adrenal cortex and, if untreated compensatory hyperandrogenism. CAH is associated with an increased cardiovascular and metabolic morbidity, possibly due to overtreatment with glucocorticoids, leading to weight gain, insulin resistance, and metabolic syndrome.
Design, participants, measurements: Thirty-seven individuals with CAH and 33 age- and sex-matched controls were evaluated at a single centre at Aarhus University Hospital with echocardiography, electrocardiogram, 24-h blood pressure, biochemistry, anthropometrics, and autism spectrum, anxiety, depression, personality, cognitive failures, and QoL were assessed using questionnaires.
Results: CAH individuals had lower height than controls (170.5 vs. 182.9 cm in males and 160.2 vs. 170.1 cm in females, p < 0.01). Compared with female controls, females with CAH had higher haemoglobin (8.8 vs. 8.2 mmol/L, p = 0.003) and BMI (29.7 vs. 25.5 kg/m2, p = 0.006), reduced insulin sensitivity (HOMA-IR): 2.7 vs. 1.9, p = 0.018), prolonged E-wave deceleration time (193 vs. 174 cm, p = 0.015), and E/é ratios (5.4 vs. 4.5, p = 0.017), and lower self-reported QoL. Males with CAH had more cognitive complaints (p = 0.034) and higher autistic scores (19.9 vs. 14.9; p = 0.068) compared with male controls. More individuals with CAH than controls reported writing problems.
Conclusion: A sex-specific comorbidity profile is evident in CAH, with females presenting with decreased metabolic and overall self-reported health, whereas males with CAH presented with increased cognitive complaints and autistic traits.
Keywords: cardiology; congenital adrenal hyperplasia; endocrinology; neuropsychology; quality of life.
© 2024 The Authors. Clinical Endocrinology published by John Wiley & Sons Ltd.
References
REFERENCES
-
- Moran C, Azziz R, Carmina E, et al. 21‐Hydroxylase‐deficient nonclassic adrenal hyperplasia is a progressive disorder: a multicenter study. Am J Obstet Gynecol. 2000;183(6):1468‐1474. doi:10.1067/mob.2000.108020
-
- El‐Maouche D, Arlt W, Merke DP. Congenital adrenal hyperplasia. Lancet. 2017;390(10108):2194‐2210. doi:10.1016/s0140-6736(17)31431-9
-
- Nimkarn S, Lin‐Su K, Berglind N, Wilson RC, New MI. Aldosterone‐to‐renin ratio as a marker for disease severity in 21‐hydroxylase deficiency congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2007;92(1):137‐142. doi:10.1210/jc.2006-0964
-
- Reisch N, Willige M, Kohn D, et al. Frequency and causes of adrenal crises over lifetime in patients with 21‐hydroxylase deficiency. Eur J Endocrinol. 2012;167(1):35‐42. doi:10.1530/eje-12-0161
-
- Berglund A, Ornstrup MJ, Lind‐Holst M, et al. Epidemiology and diagnostic trends of congenital adrenal hyperplasia in Denmark: a retrospective, population‐based study. Lancet Reg Health ‐ Europe. 2023;28:100598. doi:10.1016/j.lanepe.2023.100598
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
